[Date Prev][Date Next][Date Index]

[Neutron] OPAL Reactor reached design power of 20MW for the first time today



Title: Message

See ANSTO's press release on:  http://www.ansto.gov.au/info/press/2006/OPAL_at_20megawatts.pdf

 

OPAL reactor glows at full power

At 11:45 this morning, ANSTO's OPAL research reactor reached its full operating power of 20

Mega Watts for the first time as part of the reactor's commissioning process, which is yet to be

completed.

"This is a milestone because it means that we are a step closer to the full commissioning of the

reactor," said Dr Ian Smith, ANSTO Executive Director. "This is a very exciting time and we are

confident that the success to date in the commissioning process will assure we reach full

operation on the planned schedule and realise the science capabilities and radiopharmaceutical

production capacity which OPAL will provide for Australia.

In commissioning, reactor components and systems are made operational and verified to be in

accordance with design and performance criteria. Reaching 20 MW today is a significant

milestone for the ANSTO,INVAP (the prime contractor)and the project team.

"The water in OPAL's pool vessel is now emitting the distinctive blue glow of Cerenkov

radiation, characteristic of nuclear fission," said Dr Smith.

OPAL will be a major contributor to Australia's nuclear medicine needs for the next 40 years,

and is designed and constructed to ensure effective protection against radiological hazards for

workers, the community and the environment.

When OPAL is fully operational and delivering radioisotopes and neutron beams to the

necessary requirements, the current reactor, HIFAR, will be shut down.

___________________________________________________________________________

For more information and to arrange interviews please contact:

ANSTO Media Adviser, Sharon Kelly (02) 9717 9575 or 0400 394 085

*ANSTO is the Australian Nuclear Science and Technology Organisation, the country's national nuclear research and development

organisation and the centre of Australian nuclear expertise - over 70 per cent of all radioisotopes used in Australian nuclear

medicine are made in ANSTO's reactor.



--------------------------------------------------------------------------------------------

Robert A. Robinson
Head, The Bragg Institute, B87
Australian Nuclear Science and Technology Organisation
PMB 1, Menai NSW 2234
Australia

Tel:    +61 (2) 9717 9204
FAX:    +61 (2) 9717 3606
Mobile: 0417 017 503
E-mail: robert.robinson@ansto.gov.au

www.ansto.gov.au/ansto/bragg/index.html
www.ansto.gov.au/ansto/bragg/staff/s_rob.html

Important: This transmission is intended only for the use of the addressee. It is confidential and may contain privileged information or copyright material. If you are not the intended recipient, any use or further disclosure of this communication is strictly forbidden. If you have received this transmission in error, please notify me immediately by telephone and delete all copies of this transmission as well as any attachments.

--------------------------------------------------------------------------------------------

_______________________________________________
Neutron mailing list
Neutron@anl.gov
http://www.neutron.anl.gov/mailman/listinfo/neutron